Feasibility of Inferring Spatial Transcriptomics from Single-Cell Histological Patterns for Studying Colon Cancer Tumor Heterogeneity.
Fatemi MY, Lu Y, Sharma C, Feng E, Azher ZL, Diallo AB, Srinivasan G, Rosner GM, Pointer KB, Christensen BC, Salas LA, Tsongalis GJ, Palisoul SM, Perreard L, Kolling FW, Vaickus LJ, Levy JJ
medRxiv. 2023 Oct 9; pii: 2023.10.09.23296701. doi: 10.1101/2023.10.09.23296701. Epub 2023 Oct 9.
PMID: 37873186
MGMT Methylation Status in Grades 2 and 3 Gliomas Is Important, but Is It Prognostic?
Pointer KB, Gatson NTN
JAMA Oncol. 2023 Jul 1;9(7):928-929. doi: 10.1001/jamaoncol.2023.0759.
PMID: 37200043
Identification of Spatial Proteomic Signatures of Colon Tumor Metastasis: A Digital Spatial Profiling Approach.
Levy JJ, Zavras JP, Veziroglu EM, Nasir-Moin M, Kolling FW, Christensen BC, Salas LA, Barney RE, Palisoul SM, Ren B, Liu X, Kerr DA, Pointer KB, Tsongalis GJ, Vaickus LJ
Am J Pathol. 2023 Jun;193(6):778-795. doi: 10.1016/j.ajpath.2023.02.020. Epub 2023 Apr 8.
PMID: 37037284
Tailored Mentorship for the Underrepresented and Allies in Radiation Oncology: The Association of Residents in Radiation Oncology Equity and Inclusion Subcommittee Mentorship Experience.
Germino EA, Saripalli AL, Taparra K, Rattani A, Pointer KB, Singh SA, Musunuru HB, Shukla UC, Vidal G, Pereira IJ, Williams VM, Elmore SNC, Franco I, Chaurasia AR, Rivera A
Int J Radiat Oncol Biol Phys. 2023 Jun 1;116(2):368-374. doi: 10.1016/j.ijrobp.2023.02.003. Epub 2023 Feb 12.
PMID: 36787853
Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockade.
Spurr LF, Martinez CA, Kang W, Chen M, Zha Y, Hseu R, Gutiontov SI, Turchan WT, Lynch CM, Pointer KB, Chang P, Murgu S, Husain AN, Cody B, Vokes EE, Bestvina CM, Patel JD, Diehn M, Gajewski TF, Weichselbaum RR, Chmura SJ, Pitroda SP
Nat Cancer. 2022 Dec;3(12):1498-1512. doi: 10.1038/s43018-022-00467-x. Epub 2022 Nov 28.
PMID: 36443406
Predictors of Pneumonitis in Combined Thoracic Stereotactic Body Radiation Therapy and Immunotherapy.
Korpics MC, Katipally RR, Partouche J, Cutright D, Pointer KB, Bestvina CM, Luke JJ, Pitroda SP, Dignam JJ, Chmura SJ, Juloori A
Int J Radiat Oncol Biol Phys. 2022 Nov 15;114(4):645-654. doi: 10.1016/j.ijrobp.2022.06.068. Epub 2022 Jun 23.
PMID: 35753553
Radiotherapy and immunotherapy: open questions and future strategies.
Pointer KB, Pitroda SP, Weichselbaum RR
Trends Cancer. 2022 Jan;8(1):9-20. doi: 10.1016/j.trecan.2021.10.003. Epub 2021 Nov 2.
PMID: 34740553
A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study.
Bestvina CM, Pointer KB, Karrison T, Al-Hallaq H, Hoffman PC, Jelinek MJ, Juloori A, Melotek JM, Murgu S, Partouche J, Vokes EE, Weichselbaum RR, Pitroda SP, Patel JD, Chmura SJ
J Thorac Oncol. 2022 Jan;17(1):130-140. doi: 10.1016/j.jtho.2021.08.019. Epub 2021 Sep 6.
PMID: 34500113
Radiation treatment planning study to investigate feasibility of delivering Immunotherapy in Combination with Ablative Radiosurgery to Ultra-High DoSes (ICARUS).
Rokni MB, Pointer KB, George J, Luke JJ, Chmura SJ, Redler G
J Appl Clin Med Phys. 2021 Mar;22(3):196-206. doi: 10.1002/acm2.13204. Epub 2021 Feb 24.
PMID: 33626240
Navigating the Collagen Jungle: The Biomedical Potential of Fiber Organization in Cancer.
Ouellette JN, Drifka CR, Pointer KB, Liu Y, Lieberthal TJ, Kao WJ, Kuo JS, Loeffler AG, Eliceiri KW
Bioengineering (Basel). 2021 Jan 21;8(2) doi: 10.3390/bioengineering8020017. Epub 2021 Jan 21.
PMID: 33494220